Related Experiment Video
Updated: Jan 25, 2026

Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
Renovascular Hypertension: Novel Insights
Chrysoula Boutari1, Eleni Georgianou1, Alexandros Sachinidis1
1Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, 49 Konstantinoupoleos, Thessaloniki, 54642, Greece.
Renovascular hypertension (RVH), caused by renal artery stenosis (RAS), is a reversible hypertension cause. Revascularization shows no superiority over medication, limiting its use to specific severe cases.
Area of Science:
- Nephrology
- Cardiology
- Vascular Medicine
Background:
- Renovascular hypertension (RVH) is a significant cause of secondary hypertension.
- Renal artery stenosis (RAS), due to atherosclerosis or fibromuscular dysplasia, underlies RVH.
- RVH can lead to renal damage, cardiovascular issues, and flash pulmonary edema.
Purpose of the Study:
- To review the causes, diagnosis, and treatment of renovascular hypertension.
- To evaluate the efficacy of renal artery revascularization versus medical therapy.
- To define current recommendations for RVH management.
Main Methods:
- Literature review of diagnostic modalities including Duplex Doppler ultrasonography, CT angiography, and MR angiography.
- Analysis of therapeutic options: medical management, percutaneous angioplasty, and surgical revascularization.
- Evaluation of evidence from major clinical trials comparing revascularization and medical therapy.
Main Results:
- Diagnostic methods like ultrasound and angiography are commonly employed.
- Medical therapy, angioplasty, and surgery are available treatments.
- Large trials did not prove revascularization superior to medication for blood pressure control or renal function preservation.
Conclusions:
- Renal artery revascularization is now reserved for specific RVH cases with worsening renal function or recurrent flash pulmonary edema.
- Further research is needed to identify patient subgroups that may benefit from revascularization.
- Current evidence supports medical management as a primary treatment for most RVH patients.
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension III: Clinical Manifestations and Diagnostic Studies

